Doctor of Optometry Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Justine Siergey

Optometrist, Corneal and Contact Management Orlando, FL Doctor of Optometry

NPI 1588925622 CMS profile 71552

8701 Maitland Summit Blvd, Orlando, FL 32810

Open in the dashboard

General payments

$20,871

48 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Justine Siergey of Orlando, FL is reported in the CMS Open Payments database as having received $20,871 across 48 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Optometrist, Corneal and Contact Management profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $29 1
2023 General $152 6
2022 General $170 3
2021 General $2,702 7
2020 General $9,650 18
2019 General $8,168 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Justine Siergey
  • Optometrist, Corneal and Contact Management median
  • Middle half of Optometrist, Corneal and Contact Management
  • National median

In program year 2025, general payments to Justine Siergey were reported at $0. Among 618 Optometrist, Corneal and Contact Management profiles paid that year, the median was $227 and the middle half received between $95 and $604.

Show as a table
Year Justine Siergey Optometrist, Corneal and Contact Management median Middle half National median
2019 $8,168 $203 $84–$530 $163
2020 $9,650 $88 $35–$234 $114
2021 $2,702 $143 $54–$353 $132
2022 $170 $167 $65–$422 $149
2023 $152 $195 $76–$549 $160
2024 $29 $202 $85–$523 $164
2025 $0 $227 $95–$604 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Alcon Vision LLC $19,035 30 payments
  2. CooperVision Inc. $1,498 6 payments
  3. Visioneering Technologies, Inc. $121 3 payments
  4. Bausch & Lomb Americas Inc. $90 2 payments
  5. Oyster Point Pharma, Inc. $45 3 payments
  6. Tarsus Pharmaceuticals, Inc. $29 1 payment
  7. Bausch & Lomb, a division of Bausch Health US, LLC $23 1 payment
  8. Johnson & Johnson Surgical Vision, Inc. $17 1 payment
  9. Sun Pharmaceutical Industries Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $15,120 12 payments
  2. Travel and Lodging $2,689 10 payments
  3. Food and Beverage $1,812 25 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,250 1 payment
Products named General payments · program years 2019–2024
  1. AIR OPTIX $7,170 8 payments
  2. Precision 1 $3,212 6 payments
  3. DAILIES TOTAL1 $2,733 5 payments
  4. Onefit Contact Lens $1,480 5 payments
  5. DAILIES $1,155 1 payment
  6. TYRVAYA $45 3 payments
  7. XDEMVY $29 1 payment
  8. ENVISTA $23 1 payment
  9. Wavelight $20 1 payment
  10. Paragon CRT $18 1 payment
  11. Other $74 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

48 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist, Corneal and Contact Management in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record